Skip to content
BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · SMALL CAP

China Foods Holdings Ltd. CFOO

19 fiscal years on record · USD · FY2025 reported · SEC filings only
$327,871
▲ 40.5% YoY
$-398,672

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Substantially all of our operations are conducted in China, and are governed by Chinese laws, rules and regulations. Our health products are designed to help enhance immunity and improve general wellbeing. We provide the following categories of healthcare products, wine and customized healthcare consultation services in China: (i) Nutrition Catering (ii) Special Health Food (iii) Health Supplement (iv) Skincare and (v) wine. We also extend our service scope to provide personalized health consulting services to our clients, as well as consultancy services such as tailor-made natural food supplement solutions. We are focused on achieving long-term growth in revenues, cash flow and profit.

Written from the business description in China Foods Holdings Ltd.'s annual report to the U.S. Securities and Exchange Commission, filed 16 April 2026. Every sentence was checked against that document before publication.

Growth

USD 327,871.00
Revenue, FY2025 · full 19-year series below
Revenue $M Net income $M
FY2025 · Revenue 0.3 · Net income -0.4
1.5M3.0M-0.2M-0.4M
2007201020132016201920222025
Compound annual growth
−2.5%
−20.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −20.2% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−122 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -121.7% · Net -121.6%
50%100%-100%-200%
200720162025
ROE
FY2022 · ROE -169.4%
-50%-100%-150%
200720162025
Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.
Gross margin9.1%
Operating margin-121.7%
Net margin-121.6%
EBITDAUSD -391,934.00

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $
FY2024 · FCF -377266.0
250000.0500000.0-200000.0-400000.0
200720162025

Total assetsUSD 212,890.00
EquityUSD -1.3M
CashUSD 9,893.00
Current ratio0.11×

Equity funds -600% of total assets.

The 19-year record

19 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
CFOO, 19-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0◌◌◌
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.0◌◌◌◌◌◌◌◌◌
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.00.0◌◌◌◌◌◌◌◌◌◌◌◌
Income tax $B◌0.0◌0.00.00.00.00.00.00.00.00.00.00.00.00.0◌◌◌
Net income $B−0.0−0.0−0.0−0.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B◌−0.0−0.0◌−0.00.00.0◌◌◌◌◌◌◌◌◌◌◌◌
EPS, diluted $−0.02−0.02−0.02−0.02−0.02−0.030.01−0.01−0.01−0.01−0.01−0.01−0.010.000.000.00◌◌◌
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————————————————
ROE %———−169.4−73.7−42.1—————————————
Shares out B0.020.020.020.020.020.020.010.010.010.010.010.010.010.010.010.010.010.010.01

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 80 reconciliationsAUDITED

Reconciled in 19 of the 19 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: EPS is not tagged before 2010. Three checks were skipped: revenue is not tagged before 2010.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2007

Share this section

Download image